Daniele Panconesi

50. PHARMACOGENETICS TESTING TO OPTIMISE PRESCRIBING IN PSYCHOSIS

Background Several antipsychotics, and most antidepressants, have pharmacogenetic clinical guidelines as well as FDA/MHRA/EMA approved labels providing recommendations on drug selection or dose adjustments based on genetic data. However, implementation of pharmacogenetics testing...